Cogstate computerized cognitive tests have been designed and validated to withstand the numerous operational challenges of conducting clinical trials — dramatically increasing the sensitivity and specificity of the measurement of cognition in clinical research. The tests are highly standardized for non-expert administration, rapid and repeatable with limited learning effect, and the novel stimuli and translations into over 70 languages make it easily adopted in global clinical trials. In this short video Dr. Adrian Schembri, Cogstate Director of Clinical Science, expands on these important advantages.
© 2024 Cogstate Ltd.
Cogstate acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the lands where many of our team members live and work. We pay respect to their Elders past and present.